Expression of αCD133 autoantibodies in plasma of healthy controls or SCLC patients in 2 prediagnostic cohorts from CHS and prostate, lung, colorectal, and ovarian screening trial. *P < 0.05 using 2-way ANOVA and Bonferroni adjustment. PLCO = prostate, lung, colorectal, and ovarian.